GLIOLA
pharmaceutical products for the treatment of infectious diseases; nutritive substances for microorganisms for medical use; cellular function activating agents for medical purposes; dietetic substances adapted for medical use; pharmaceuticals; dermatological pharmaceutical products; Stem cells for medical use; Gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants grown from stem cells
Pending · April 12, 2024 · 98496546 ·